Hermansky–Pudlak syndrome

From WikiMD's Medical Encyclopedia

(Redirected from Hermansky Pudlak syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Hermansky–Pudlak syndrome
Synonyms HPS
Pronounce
Specialty Genetics, Hematology
Symptoms Albinism, bleeding disorder, pulmonary fibrosis, colitis
Complications N/A
Onset Varies
Duration Lifelong
Types N/A
Causes Mutations in one of several genes
Risks
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Chediak–Higashi syndrome, Griscelli syndrome
Prevention N/A
Treatment Supportive care, lung transplantation
Medication
Prognosis Variable, depends on complications
Frequency Rare
Deaths


Hermansky–Pudlak syndrome (HPS) is a rare autosomal recessive disorder which results in oculocutaneous albinism (decreased pigmentation), bleeding problems due to a platelet abnormality, and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin).

Signs and Symptoms[edit]

The symptoms of Hermansky-Pudlak syndrome can vary greatly from person to person. However, most individuals with this condition have oculocutaneous albinism, which causes vision problems and reduces the color of the skin, hair, and eyes. People with this condition also have a bleeding disorder, which makes it difficult for the blood to clot and stop bleeding.

Causes[edit]

Hermansky-Pudlak syndrome is caused by mutations in one of at least nine different genes. These genes are involved in the formation and function of specialized compartments within cells called lysosomes and melanosomes.

Diagnosis[edit]

Diagnosis of Hermansky-Pudlak syndrome is based on the clinical findings of oculocutaneous albinism and a bleeding diathesis. Genetic testing can confirm the diagnosis.

Treatment[edit]

Treatment of Hermansky-Pudlak syndrome is symptomatic and supportive. It may include avoidance of sun exposure, use of protective eyewear, and treatment of bleeding episodes with desmopressin or antifibrinolytic agents.

Prognosis[edit]

The prognosis for individuals with Hermansky-Pudlak syndrome varies. Some individuals may have a normal lifespan with few related health issues, while others may have life-threatening complications such as pulmonary fibrosis.

See Also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.